Titre : Personnes se prêtant à la recherche

Personnes se prêtant à la recherche : Questions médicales fréquentes

Termes MeSH sélectionnés :

Intervertebral Disc Displacement
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Personnes se prêtant à la recherche : Questions médicales les plus fréquentes", "headline": "Personnes se prêtant à la recherche : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Personnes se prêtant à la recherche : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-25", "dateModified": "2025-04-19", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Personnes se prêtant à la recherche" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Personnes", "url": "https://questionsmedicales.fr/mesh/D009272", "about": { "@type": "MedicalCondition", "name": "Personnes", "code": { "@type": "MedicalCode", "code": "D009272", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "M01" } } }, "about": { "@type": "MedicalCondition", "name": "Personnes se prêtant à la recherche", "alternateName": "Research Subjects", "code": { "@type": "MedicalCode", "code": "D035842", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Stephanie Morain", "url": "https://questionsmedicales.fr/author/Stephanie%20Morain", "affiliation": { "@type": "Organization", "name": "Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX." } }, { "@type": "Person", "name": "Kemal Hakan Gülkesen", "url": "https://questionsmedicales.fr/author/Kemal%20Hakan%20G%C3%BClkesen", "affiliation": { "@type": "Organization", "name": "Peter L. Reichertz Institute for Medical Informatics, TU Braunschweig and Hannover Medical School, Braunschweig, Germany." } }, { "@type": "Person", "name": "Reinhold Haux", "url": "https://questionsmedicales.fr/author/Reinhold%20Haux", "affiliation": { "@type": "Organization", "name": "Peter L. Reichertz Institute for Medical Informatics, TU Braunschweig and Hannover Medical School, Braunschweig, Germany." } }, { "@type": "Person", "name": "Sungwoo Um", "url": "https://questionsmedicales.fr/author/Sungwoo%20Um", "affiliation": { "@type": "Organization", "name": "Department of Ethics Education, Seoul National University, 1, Gwanak-Ro, 11-411, Gwanak-Gu, 08826, South Korea. sungwooum@snu.ac.kr." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Role of Necroptosis in Intervertebral Disc Degeneration.", "datePublished": "2023-10-18", "url": "https://questionsmedicales.fr/article/37894970", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms242015292" } }, { "@type": "ScholarlyArticle", "name": "The influence of geometry on intervertebral disc stiffness.", "datePublished": "2024-01-05", "url": "https://questionsmedicales.fr/article/38233311", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jbiomech.2023.111915" } }, { "@type": "ScholarlyArticle", "name": "Factors associated with disc degeneration based on Pfirrmann criteria after condoliase treatment for lumbar disc herniation.", "datePublished": "2022-08-25", "url": "https://questionsmedicales.fr/article/36030156", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jos.2022.08.001" } }, { "@type": "ScholarlyArticle", "name": "Intervertebral Disc Progenitors: Lessons Learned from Single-Cell RNA Sequencing and the Role in Intervertebral Disc Regeneration.", "datePublished": "2023-06-12", "url": "https://questionsmedicales.fr/article/37370644", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/bioengineering10060713" } }, { "@type": "ScholarlyArticle", "name": "Epigenetic regulation in intervertebral disc degeneration.", "datePublished": "2022-08-24", "url": "https://questionsmedicales.fr/article/36030154", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.molmed.2022.07.007" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Personnes", "item": "https://questionsmedicales.fr/mesh/D009272" }, { "@type": "ListItem", "position": 3, "name": "Personnes se prêtant à la recherche", "item": "https://questionsmedicales.fr/mesh/D035842" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Personnes se prêtant à la recherche - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Personnes se prêtant à la recherche", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Personnes se prêtant à la recherche", "description": "Comment sont sélectionnés les sujets de recherche ?\nQuels tests sont effectués sur les sujets ?\nLes sujets sont-ils informés des risques ?\nComment évaluer la santé des sujets ?\nQuelles données sont collectées sur les sujets ?", "url": "https://questionsmedicales.fr/mesh/D035842?mesh_terms=Intervertebral+Disc+Displacement&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Personnes se prêtant à la recherche", "description": "Les sujets ressentent-ils des effets secondaires ?\nComment les symptômes sont-ils suivis ?\nLes symptômes varient-ils selon les traitements ?\nLes sujets peuvent-ils signaler des symptômes ?\nY a-t-il un suivi des symptômes après l'étude ?", "url": "https://questionsmedicales.fr/mesh/D035842?mesh_terms=Intervertebral+Disc+Displacement&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Personnes se prêtant à la recherche", "description": "Les sujets reçoivent-ils des conseils préventifs ?\nY a-t-il des vaccinations pour les sujets ?\nComment prévenir les effets indésirables ?\nLes sujets sont-ils formés à la prévention ?\nY a-t-il des recommandations diététiques ?", "url": "https://questionsmedicales.fr/mesh/D035842?mesh_terms=Intervertebral+Disc+Displacement&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Personnes se prêtant à la recherche", "description": "Quels types de traitements sont testés ?\nLes traitements sont-ils randomisés ?\nComment les traitements sont-ils administrés ?\nLes sujets reçoivent-ils un placebo ?\nComment évaluer l'efficacité des traitements ?", "url": "https://questionsmedicales.fr/mesh/D035842?mesh_terms=Intervertebral+Disc+Displacement&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Personnes se prêtant à la recherche", "description": "Quelles complications peuvent survenir ?\nComment sont gérées les complications ?\nLes sujets sont-ils suivis après des complications ?\nLes complications sont-elles documentées ?\nY a-t-il des critères pour signaler des complications ?", "url": "https://questionsmedicales.fr/mesh/D035842?mesh_terms=Intervertebral+Disc+Displacement&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Personnes se prêtant à la recherche", "description": "Quels facteurs de risque sont évalués ?\nLes sujets sont-ils informés des facteurs de risque ?\nComment les facteurs de risque influencent-ils l'étude ?\nLes facteurs de risque sont-ils mesurés ?\nY a-t-il des interventions pour réduire les risques ?", "url": "https://questionsmedicales.fr/mesh/D035842?mesh_terms=Intervertebral+Disc+Displacement&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment sont sélectionnés les sujets de recherche ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les sujets sont choisis selon des critères spécifiques liés à l'étude." } }, { "@type": "Question", "name": "Quels tests sont effectués sur les sujets ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests cliniques, biologiques et d'imagerie peuvent être réalisés." } }, { "@type": "Question", "name": "Les sujets sont-ils informés des risques ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'information sur les risques est essentielle avant le consentement." } }, { "@type": "Question", "name": "Comment évaluer la santé des sujets ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des évaluations médicales régulières sont effectuées tout au long de l'étude." } }, { "@type": "Question", "name": "Quelles données sont collectées sur les sujets ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des données démographiques, cliniques et de réponse au traitement sont collectées." } }, { "@type": "Question", "name": "Les sujets ressentent-ils des effets secondaires ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets secondaires peuvent survenir et doivent être signalés." } }, { "@type": "Question", "name": "Comment les symptômes sont-ils suivis ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes sont suivis par des questionnaires et des évaluations cliniques." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon les traitements ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction du traitement administré." } }, { "@type": "Question", "name": "Les sujets peuvent-ils signaler des symptômes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les sujets sont encouragés à signaler tout symptôme nouveau ou aggravé." } }, { "@type": "Question", "name": "Y a-t-il un suivi des symptômes après l'étude ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi peut être proposé pour évaluer les effets à long terme." } }, { "@type": "Question", "name": "Les sujets reçoivent-ils des conseils préventifs ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des conseils sur la santé et la prévention des maladies peuvent être fournis." } }, { "@type": "Question", "name": "Y a-t-il des vaccinations pour les sujets ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des vaccinations peuvent être administrées selon les protocoles de l'étude." } }, { "@type": "Question", "name": "Comment prévenir les effets indésirables ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des mesures préventives et un suivi régulier aident à minimiser les effets indésirables." } }, { "@type": "Question", "name": "Les sujets sont-ils formés à la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une formation sur la prévention des maladies peut être incluse dans l'étude." } }, { "@type": "Question", "name": "Y a-t-il des recommandations diététiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des recommandations diététiques peuvent être fournies pour améliorer la santé des sujets." } }, { "@type": "Question", "name": "Quels types de traitements sont testés ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments, des thérapies physiques et des interventions chirurgicales peuvent être testés." } }, { "@type": "Question", "name": "Les traitements sont-ils randomisés ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreuses études utilisent des méthodes randomisées pour réduire les biais." } }, { "@type": "Question", "name": "Comment les traitements sont-ils administrés ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements peuvent être administrés par voie orale, intraveineuse ou topique." } }, { "@type": "Question", "name": "Les sujets reçoivent-ils un placebo ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Dans certaines études, un groupe de sujets peut recevoir un placebo pour comparaison." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité des traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est évaluée par des mesures cliniques et des questionnaires standardisés." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications liées aux traitements ou à la maladie peuvent survenir." } }, { "@type": "Question", "name": "Comment sont gérées les complications ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont gérées par des interventions médicales appropriées." } }, { "@type": "Question", "name": "Les sujets sont-ils suivis après des complications ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi est souvent prévu pour évaluer la récupération des sujets." } }, { "@type": "Question", "name": "Les complications sont-elles documentées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, toutes les complications doivent être soigneusement documentées dans l'étude." } }, { "@type": "Question", "name": "Y a-t-il des critères pour signaler des complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des critères spécifiques sont établis pour le signalement des complications." } }, { "@type": "Question", "name": "Quels facteurs de risque sont évalués ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme l'âge, le sexe, et les antécédents médicaux sont évalués." } }, { "@type": "Question", "name": "Les sujets sont-ils informés des facteurs de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les sujets reçoivent des informations sur les facteurs de risque associés à l'étude." } }, { "@type": "Question", "name": "Comment les facteurs de risque influencent-ils l'étude ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent influencer les résultats et la généralisation des conclusions de l'étude." } }, { "@type": "Question", "name": "Les facteurs de risque sont-ils mesurés ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des questionnaires et des évaluations médicales mesurent les facteurs de risque." } }, { "@type": "Question", "name": "Y a-t-il des interventions pour réduire les risques ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Des interventions peuvent être proposées pour réduire les facteurs de risque identifiés." } } ] } ] }

Sources (4692 au total)

Factors associated with disc degeneration based on Pfirrmann criteria after condoliase treatment for lumbar disc herniation.

Lumbar disc herniation (LDH) is a common cause of low back pain and is associated with degeneration of the nucleus pulposus causing nerve root compression. Chemonucleolysis of the nucleus pulposus wit... Medical records and radiographic findings were reviewed retrospectively for 127 patients with LDH (88 male, 39 female, mean age: 46.6 ± 17.1 years, mean follow-up: 9.8 ± 7.8 months) who underwent chem... Cases in which the Pfirrmann grade did and did not progress in the 3 months after the injection were included in groups P (progression, n = 49) and NP (non-progression, n = 78), respectively. Logistic... These results show the safety and efficacy of chemonucleolysis with condoliase for treatment of painful LDH. Progression of Pfirrmann criteria on MRI at 3 months after injection was significantly asso...

Effect of Nonsurgical Spinal Decompression on Intensity of Pain and Herniated Disc Volume in Subacute Lumbar Herniated Disc.

Nonsurgical spinal decompression therapy (NSDT) is a conservative treatment for the lumbosacral herniated intervertebral disc (L-HIVD). This study aimed to evaluate the clinical effectiveness of the N... Sixty patients with subacute L-HIVD were randomized into either the decompression group (group D,... The lower leg pain intensity in group D was lower than that in group N at two months (... NSDT may be a suitable treatment option for conservative treatment of subacute L-HIVD....

Correlation between inflammatory cytokine expression in paraspinal tissues and severity of disc degeneration in individuals with lumbar disc herniation.

Previous animal studies have discovered dysregulation of the local inflammatory state as a novel mechanism to explain structural changes in paraspinal muscles in association with disc degeneration. Th... Muscles were procured from 60 individuals undergoing percutaneous endoscopic lumbar discectomy for lumbar disc herniation (LDH). Total and functional CSAs and fatty degeneration of paraspinal muscles ... There were significant differences in total CSAs of paraspinal muscles and functional CSA and fatty degeneration of MM between ipsilateral and unilateral sides. Participants in the disc degeneration g... The results show that there were differences in the characteristics of paraspinal muscles between the ipsilateral and unilateral sides, which were affected by disc degeneration and the degree of fat i...

Intervertebral disc injury triggers neurogenic inflammation of adjacent healthy discs.

Intervertebral disc degeneration is common and may play a role in low back pain, but it is not well-understood. Previous studies have shown that the outer layer of the annulus fibrosus of a healthy di... This study was based on animal experiments in Sprague-Dawley rats to investigate the role of neurogenic inflammation in adjacent healthy disc degeneration induced by disc injury.... This was an experimental study.... Seventy-five 12-week-old, male Sprague-Dawley rats were allocated to 3 groups (sham group, disc injury group and disc injury+TrkA antagonist group). The disc injury group was punctured in the tail dis... Disc injury induced an increase in aggrecan, NGF, TrkA, CGRP, SP, IL-1β, and IL-6 mRNA levels in the injured (Co8-9) and adjacent discs (Co7-8), which reached a peak on day 1, then gradually decreased... Degeneration of one disc can induce neurogenic inflammation of adjacent healthy discs in a rat model.... This model supports a role of neurogenic inflammation in disc degeneration, and may play a role in the experience of low back pain....

Disc degeneration contributes to the denser bone in the subendplate but not in the vertebral body in patients with lumbar spinal stenosis or disc herniation.

It is commonly believed that decreased bone quality would lead to endplate degeneration and arthritic changes in the facet joints, and thus accelerated disc degeneration (DD). However, some more detai... To evaluate MRI-based vertebral bone quality and Pfirrmann grades in patients with lumbar spinal stenosis or disc herniation, and to identify if DD is associated with denser bone around the endplate.... A single-center, retrospective cohort study.... A total of 130 patients with lumbar disc herniation and lumbar spinal stenosis from January 2019 to November 2020 who had a complete dual-energy X-ray absorptiometry scan and noncontrast lumbosacral s... The vertebral bone quality score (VBQ) and sub-endplate bone quality score (EBQ) was calculated as a ratio of the signal intensity of the vertebral bodies and sub-endplate regions to the signal intens... The age, gender, body mass index, and T-score of the lumbar spine of the patients were collected. The degeneration grades of the lumbar discs were evaluated according to the Pfirrmann classification. ... This study included 569 lumbar segments from 130 inpatients. Cranial and caudal EBQ decreased with the increase of the Pfirrmann grade. The discs with Pfirrmann grade 5 had significantly lower caudal ... Disc degeneration grades correlated with the EBQ but not with the VBQ. In patients with lumbar spinal stenosis or disc herniation, DD contributes to the denser bone in the sub-endplate, but not in the...